Short Interest in Halberd Co. (OTCMKTS:HALB) Decreases By 54.6%

Halberd Co. (OTCMKTS:HALB) saw a significant drop in short interest in June. As of June 30th, there was short interest totaling 186,263 shares, a drop of 54.6% from the June 15th total of 409,891 shares. Based on an average trading volume of 1,164,131 shares, the short-interest ratio is presently 0.2 days.

Halberd Stock Down 22.2%

HALB stock traded down $0.00 during midday trading on Wednesday, hitting $0.00. The company’s stock had a trading volume of 350 shares, compared to its average volume of 784,248. Halberd has a 12 month low of $0.00 and a 12 month high of $0.00.

Halberd Company Profile

Halberd Corporation, a biotech company, develops treatments for neurodegenerative diseases. It offers treatments for post traumatic stress disorder/chronic traumatic encephalopathy, Alzheimer's and Parkinson's disease, cancer, blood-borne, and cerebrospinal fluid related diseases. The company was incorporated in 2009 and is based in Jackson Center, Pennsylvania.